ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models
Linxi Zhu(Wenzhou University), Rodney J. Y. Ho(University of Washington), Qingxin Mu(St. Jude Children's Research Hospital), Jesse Yu(University of Washington), Xiaolin Xu(Southern Medical University), James I. Griffin(University of Washington)
Cited by 18
Related Papers
Size-Dependent Cell Uptake of Protein-Coated Graphene Oxide Nanosheets
|ACS Applied Materials & Interfaces|2012|364
Antiandrogenic activity of pyrethroid pesticides and their metabolite in reporter gene assay
|Chemosphere|2006|128
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
|Pharmacology & Therapeutics|2022|99
PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment
|Journal of Colloid and Interface Science|2016|84